An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Author:
LaMarche Nelson M., Hegde Samarth, Park Matthew D., Maier Barbara B., Troncoso LeannaORCID, Le Berichel Jessica, Hamon PaulineORCID, Belabed Meriem, Mattiuz RaphaëlORCID, Hennequin Clotilde, Chin Theodore, Reid Amanda M., Reyes-Torres Iván, Nemeth Erika, Zhang Ruiyuan, Olson Oakley C., Doroshow Deborah B., Rohs Nicholas C., Gomez Jorge E., Veluswamy Rajwanth, Hall Nicole, Venturini NicholasORCID, Ginhoux FlorentORCID, Liu Zhaoyuan, Buckup Mark, Figueiredo Igor, Roudko Vladimir, Miyake KensukeORCID, Karasuyama HajimeORCID, Gonzalez-Kozlova EdgarORCID, Gnjatic SachaORCID, Passegué EmmanuelleORCID, Kim-Schulze Seunghee, Brown Brian D.ORCID, Hirsch Fred R., Kim Brian S.ORCID, Marron Thomas U.ORCID, Merad MiriamORCID
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference60 articles.
1. Barry, S. T., Gabrilovich, D. I., Sansom, O. J., Campbell, A. D. & Morton, J. P. Therapeutic targeting of tumour myeloid cells. Nat. Rev. Cancer 23, 216–237 (2023). 2. Castro, M. et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N. Engl. J. Med. 378, 2486–2496 (2018). 3. Rabe, K. F. et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N. Engl. J. Med. 378, 2475–2485 (2018). 4. Simpson, E. L. et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N. Engl. J. Med. 375, 2335–2348 (2016). 5. Beck, K. M., Yang, E. J., Sekhon, S., Bhutani, T. & Liao, W. Dupilumab treatment for generalized prurigo nodularis. JAMA Dermatol. 155, 118–120 (2019).
|
|